Investor Relations

Related links

Third Quarter Results 2020
Roche's virtual event - ASH
Presentations from recent IR events

Investor updates

Published on: 21 January 2021

FDA grants priority review to Roche’s Esbriet (pirfenidone) for unclassifiable interstitial lung disease

Published on: 18 January 2021

Roche Annual General Meeting 2021: Exercising of shareholder rights via the independent proxy

Published on: 12 January 2021

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

IR events

29January

Cowen GTx Regulatory/Clinical Trial Design Panel at Virtual Gene Therapy Summit (virtual event)

(EST)

New York, US

add to calendar

4February

Roche Full Year Results 2020 (virtual event)

(CET)

Basel, CH

more add to calendar

17February

Citi's 9th Annual Immuno-oncology Leadership Summit (virtual event)

(EST)

New York, US

add to calendar

Share price

Latest annual report

Annual Report 2019 Highlights

How medicines are making an impact in the lives of patients

Finance information tool

Pipeline

Pipeline

Get up-to-date information about our pipeline.

Roche R&D

Genentech Biooncology

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

Diagnostics news

Sustainability

Sustainability download center

Sustainability at Roche

Non-financial reporting

Dividend and total return

Dividend calendar

Timetable for the payment of the 2019 dividend

Total return center

Investor tool providing analysis of total returns

Frequently asked questions

FAQ

Get answers to frequently asked questions

US investors

How to invest

Contact